Why in news?
The Union Health Ministry has allowed the use of Hydroxychloroquine in combination with Azithromycin under close monitoring for patients with severe disease and requiring ICU management as per the revised Guidelines on Clinical Management of COVID–19.
- Hydroxychloroquine was previously under testing and was allowed to be administered only to doctors and caregiver in direct contact with COVID-19 positive cases.
- The Health Ministry has noted that no specific antiviral have been proven to be effective as per currently available data.
- However, based on the available information (uncontrolled clinical trials), the following drugs may be considered.
- It has, however, cautioned that the medication is presently not recommended for children less than 12 years, pregnant and lactating women.